- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Expensive and Large Hospitals Do Not Equate to Value
While expensive hospitals might earn a better reputation, there is little evidence that they provide better care.
While expensive hospitals might earn a better reputation, there is little evidence that they provide better care.
In a study that examined the actual costs of 25,000 insurance claims from hospitals in 10 metropolitan markets, researchers discovered that expensive hospitals were much more likely to win a national ranking for high quality from US News & World Report. However, there was no evidence that they provided better care. In fact, most expensive hospitals actually performed worse than their lower-cost counterparts in areas like meeting performance goals, which include reducing readmissions and avoiding death in surgical patients.
“We found that high-price hospitals within markets were more likely to be engaged in medical education; offer specialized, expensive services typically associated with tertiary-care hospitals; and serve a higher percentage of low-income (and poorly reimbursed) patients,” the study authors wrote “But high-price hospitals also clearly enjoyed dominant market positions. Both their large size and their membership in even larger hospital systems made it difficult for health plans to negotiate lower prices with them.”
While the study authors acknowledged that some of the high costs may be due to specialized treatment offered at these larger hospitals, the study mainly focused on the costs of routine care. Larger hospitals may also treat a larger population of the sickly and poor.
“Given the intense and growing pressure to rein in the growth in private health insurance premiums, the continuation of current trends appears to be unsustainable. It remains to be seen whether or not health plans will somehow regain the upper hand,” the authors said.” If they do not, more radical approaches—such as state-based rate setting or restrictions on contracting arrangements between hospitals and health plans—may gain traction.”
The 10 metropolitan markets examined in study included: Buffalo, Cleveland; Detroit; Flint, Michigan; Indianapolis; Kansas City; St. Louis; Toledo, Ohio; Warren, Michigan; and Youngstown, Ohio.
Around the Web
Expensive Hospitals: Strong Reputations But Little Evidence Of Better Care, Study Finds [Kaiser Health News]
Understanding Differences Between High- And Low-Price Hospitals: Implications For Efforts To Rein In Costs [Health Affairs]
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage
May 7th 2024Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Senate Finance Committee has introduced bipartisan legislation that proposes using Medicaid and Medicare programs to help prevent and reduce generic drug shortages; US indicators for COVID-19, flu, and respiratory syncytial virus (RSV) declined further last week; findings from a recent study reveal growing disparities in child death rates across racial and ethnic groups.
Read More
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More
